GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Linical Co Ltd (TSE:2183) » Definitions » Price-to-Owner-Earnings

Linical Co (TSE:2183) Price-to-Owner-Earnings : (As of Jan. 18, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Linical Co Price-to-Owner-Earnings?

As of today (2025-01-18), Linical Co's share price is 円342.00. Linical Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Linical Co's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Linical Co was 94.42. The lowest was 15.60. And the median was 32.06.


TSE:2183's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 29.67
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-01-18), Linical Co's share price is 円342.00. Linical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was 円14.98. Therefore, Linical Co's PE Ratio (TTM) for today is 22.84.

As of today (2025-01-18), Linical Co's share price is 円342.00. Linical Co's EPS without NRI for the trailing twelve months (TTM) ended in was 円19.68. Therefore, Linical Co's PE Ratio without NRI for today is 17.38.

During the past 13 years, Linical Co's highest PE Ratio without NRI was 58.26. The lowest was 11.77. And the median was 24.72.


Linical Co Price-to-Owner-Earnings Historical Data

The historical data trend for Linical Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Linical Co Price-to-Owner-Earnings Chart

Linical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.13 - - - -

Linical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Linical Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, Linical Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Linical Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Linical Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Linical Co's Price-to-Owner-Earnings falls into.



Linical Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Linical Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=342.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Linical Co  (TSE:2183) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Linical Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Linical Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Linical Co Business Description

Traded in Other Exchanges
N/A
Address
10 floor brick building No. 1, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.

Linical Co Headlines

No Headlines